Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-29 · accession 0001048477-24-000156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-11-29 | BMRN | Hardy Alexander | CEO, Dir | F - Tax | $66.03 | -14.3K | 134.2K | -10% | -$943.9K | |
| 2024-12-03 | 2024-10-31 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $56.01 | +300 | 148.5K | +0.2% | +$16.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | F | D | 14,295 | $66.03 | 134,156 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-31 | A | A | 300 | $56.01 | 148,451 | D | — | — | (F1) Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan. |